JP2018525034A5 - - Google Patents

Download PDF

Info

Publication number
JP2018525034A5
JP2018525034A5 JP2018527008A JP2018527008A JP2018525034A5 JP 2018525034 A5 JP2018525034 A5 JP 2018525034A5 JP 2018527008 A JP2018527008 A JP 2018527008A JP 2018527008 A JP2018527008 A JP 2018527008A JP 2018525034 A5 JP2018525034 A5 JP 2018525034A5
Authority
JP
Japan
Prior art keywords
tumor
cell receptor
clone
nucleic acid
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018527008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018525034A (ja
JP6815400B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/069041 external-priority patent/WO2017025564A1/en
Publication of JP2018525034A publication Critical patent/JP2018525034A/ja
Publication of JP2018525034A5 publication Critical patent/JP2018525034A5/ja
Application granted granted Critical
Publication of JP6815400B2 publication Critical patent/JP6815400B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018527008A 2015-08-10 2016-08-10 腫瘍特異的t細胞を提供するための方法 Active JP6815400B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15180383 2015-08-10
EP15180383.0 2015-08-10
EP15202419.6 2015-12-23
EP15202419 2015-12-23
PCT/EP2016/069041 WO2017025564A1 (en) 2015-08-10 2016-08-10 Method for providing tumour-specific t cells

Publications (3)

Publication Number Publication Date
JP2018525034A JP2018525034A (ja) 2018-09-06
JP2018525034A5 true JP2018525034A5 (enExample) 2019-09-19
JP6815400B2 JP6815400B2 (ja) 2021-01-20

Family

ID=56738102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018527008A Active JP6815400B2 (ja) 2015-08-10 2016-08-10 腫瘍特異的t細胞を提供するための方法

Country Status (7)

Country Link
US (1) US20190255162A1 (enExample)
EP (2) EP3372683B1 (enExample)
JP (1) JP6815400B2 (enExample)
CA (1) CA3030959A1 (enExample)
DK (2) DK3180433T3 (enExample)
ES (2) ES2807026T3 (enExample)
WO (1) WO2017025564A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220112557A1 (en) * 2019-01-10 2022-04-14 Iovance Biotherapeutics, Inc. System and methods for monitoring adoptive cell therapy clonality and persistence
CA3225111A1 (en) 2021-07-15 2023-02-02 Rudolf Hammer Identification of common tumor-specific t cell receptors and antigens
EP4426320A4 (en) * 2021-11-03 2025-11-05 Univ Delaware SYSTEM FOR ADMINISTRATING CELL-DERIVED MICROPARTICLES AND ITS USES
CN114530202A (zh) * 2021-12-20 2022-05-24 深圳泛因医学有限公司 鉴定抗原特异性tcr或bcr的方法及应用
US20250368717A1 (en) 2022-05-30 2025-12-04 Hs Diagnomics Gmbh Common tumor-specific t cell receptors
EP4649952A1 (en) 2024-05-14 2025-11-19 HS Diagnomics GmbH Kras q16h specific t cell receptors and uses thereof
WO2025238079A1 (en) 2024-05-14 2025-11-20 Hs Diagnomics Gmbh Kras q16h specific t cell receptors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128153D0 (en) * 2001-11-23 2002-01-16 Bayer Ag Profiling of the immune gene repertoire
DE102004063339A1 (de) 2004-12-23 2006-07-06 Bayer Technology Services Gmbh Sonde zum Nachweis von Nukleinsäuren
EP2980225B1 (en) * 2012-04-20 2017-11-08 Alacris Theranostics GmbH Cdr sequence-specific enrichment of live immune cells
EP2746405B1 (en) 2012-12-23 2015-11-04 HS Diagnomics GmbH Methods and primer sets for high throughput PCR sequencing
JP6164759B2 (ja) * 2013-11-21 2017-07-19 Repertoire Genesis株式会社 T細胞受容体およびb細胞受容体レパトアの解析システムならびにその治療および診断への利用

Similar Documents

Publication Publication Date Title
JP2018525034A5 (enExample)
US12351872B2 (en) Determining antigen-specific T-cells
JP6383789B2 (ja) 配列タグによる大規模生体分子解析
Francica et al. Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization
Warren et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes
CA2999888C (en) Affinity-oligonucleotide conjugates and uses thereof
JP2021166532A (ja) 腫瘍試料の多重遺伝子分析
US20210087610A9 (en) Methods for analyzing t cell receptors and b cell receptors
JP6085249B2 (ja) 複雑なアンプリコンの配列解析
JP6929354B2 (ja) 親和性−オリゴヌクレオチドコンジュゲートおよびその使用
Liu et al. Characterization of human αβTCR repertoire and discovery of DD fusion in TCRβ chains
JP2013539970A5 (enExample)
EP4234576A3 (en) Methods of isolating neoantigen-specific t cell receptor sequences
JP2016000057A5 (enExample)
JP2015501658A (ja) 組織浸潤リンパ球の検出および測定方法
EP2702146A2 (en) Identification of polynucleotides associated with a sample
US11319590B2 (en) Enhanced immune cell receptor sequencing methods
WO2008026927A2 (en) Process for displaying t- and b-cell receptor repertoires
US20210317522A1 (en) Phenotypic and molecular characterisation of single cells
JP2020527036A5 (enExample)
JP2019517774A (ja) 核酸を濃縮及びキャプチャーするためのプローブと設計方法
WO2015200701A3 (en) Software haplotying of hla loci
RU2014102617A (ru) Выявление аффинно-зрелых человеческих антител
JP2014521316A5 (enExample)
Dambrot et al. Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones